Fig. 2From: Influence on [18F]FDG uptake by cancer cells after anti-PD-1 therapy in an enforced-immune activated mouse tumorEx vivo validation of [18F]FDG uptake. a Ex vivo biodistribution of tumors, spleens, and blood on day 7 (n = 6–7). Data of the non-treatment group and anti-PD-1-treated group were quoted from [11]. b HE-stained tissue sections and autoradiograms of the cGAMP-treated group and the cGAMP/anti-PD-1 combination group tumors. Data represent the mean ± SEM; *p < 0.05; † Adapted from [11]Back to article page